Literature DB >> 6300294

Herpes simplex virus type 1-induced interferon production and activation of natural killer cells in mice.

H Kirchner, H Engler, C H Schröder, R Zawatzky, E Storch.   

Abstract

Cultures of peritoneal exudate cells (PEC) of non-immune C57BL/6 mice reacted to infectious herpes simplex virus type 1 (HSV), but not to non-infectious virions by producing interferon. Similarly, when the virus preparations were injected intraperitoneally (i.p.) and interferon was determined in the wash-out fluid, interferon could only be detected after injection of infectious HSV. All interferons were mixtures of interferon-alpha and -beta. The cell that produced interferon was not sensitive to anti-theta serum or anti-asialo-GM1 serum, it was retained on nylon wool columns and removed by plastic adherence. Silica treatment of PEC abolished HSV-induced interferon production whereas irradiation by 2000 R was without effect. Pure cultures of mouse T cells did not produce interferon when treated with infectious HSV whereas pure cultures of mouse bone marrow macrophages did produce interferon. Thus, we suggest that in PEC the cells which produced interferon were of the macrophage lineage. In further experiments we have analysed in vivo activation of natural killer (NK) cells in the peritoneal cavity of mice. Non-infectious virions were as effective as infectious HSV and doses of HSV too low to induce measurable titres of interferon caused a marked activation of NK cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6300294     DOI: 10.1099/0022-1317-64-2-437

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

Review 1.  Animal models of herpes simplex virus immunity and pathogenesis.

Authors:  Christina M Kollias; Richard B Huneke; Brian Wigdahl; Stephen R Jennings
Journal:  J Neurovirol       Date:  2014-11-12       Impact factor: 2.643

2.  Effect of interferon on replication of herpes simplex virus types 1 and 2 in human macrophages.

Authors:  I Domke-Opitz; P Straub; H Kirchner
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

3.  Injection of mice with antibody to interferon renders peritoneal macrophages permissive for vesicular stomatitis virus and encephalomyocarditis virus.

Authors:  F Belardelli; F Vignaux; E Proietti; I Gresser
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

4.  Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways.

Authors:  Hubertus Hochrein; Beatrix Schlatter; Meredith O'Keeffe; Cornelia Wagner; Frank Schmitz; Matthias Schiemann; Stefan Bauer; Mark Suter; Hermann Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-22       Impact factor: 11.205

5.  Differences in the mechanism of induction of interferon-alpha by herpes simplex virus and herpes simplex virus-infected cells.

Authors:  M R Capobianchi; F Malavasi; P Di Marco; F Dianzani
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

6.  Thy 1+ asialo GM1+ dendritic epidermal cells in skin defense mechanisms of vaccinia virus-infected mice.

Authors:  S Ikeda; T Tominaga; C Nishimura
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

7.  Experimental infection of inbred mice with herpes simplex virus. VI. Effect of interferon on in vitro virus replication in macrophages.

Authors:  J Brücher; I Domke; C H Schröder; H Kirchner
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

8.  Pathogen recognition receptor signaling accelerates phosphorylation-dependent degradation of IFNAR1.

Authors:  Juan Qian; Hui Zheng; Wei-Chun Huangfu; Jianghuai Liu; Christopher J Carbone; N Adrian Leu; Darren P Baker; Serge Y Fuchs
Journal:  PLoS Pathog       Date:  2011-06-09       Impact factor: 6.823

Review 9.  Macrophages and cytokines in the early defence against herpes simplex virus.

Authors:  Svend Ellermann-Eriksen
Journal:  Virol J       Date:  2005-08-03       Impact factor: 4.099

10.  Protection of mice against infection with mouse hepatitis virus type 3 by injection of silica.

Authors:  L Schindler; J Brücher; H Kirchner
Journal:  Immunobiology       Date:  1984-01       Impact factor: 3.144

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.